| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 07/13/2006 | US20060154916 Condensed azepines as vasopressin agonists |
| 07/13/2006 | US20060154907 Method of treating hormonal deficiencies in women undergoing estrogen replacement therapy |
| 07/13/2006 | US20060153801 Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
| 07/13/2006 | US20060151899 Process for producing drug ultramicroparticle and apparatus therefor |
| 07/13/2006 | DE102004063752A1 Verwendung ausgewählter CGRP-Antagonisten zur Bekämpfung menopausaler Hitzewallungen Use of selected CGRP antagonists to combat menopausal hot flashes |
| 07/13/2006 | CA2593768A1 Use of .omega.3 unsaturated fatty acids for relieving lipotoxicity |
| 07/13/2006 | CA2593335A1 The use of a lignan for the manufacture of a composition for preventing or alleviating of symptoms relating to estrogen deficiency |
| 07/12/2006 | EP1679316A1 Stable vitamin b6 derivative |
| 07/12/2006 | EP1496865B1 Method for the production of crystals, crystals obtained by said method, and use thereof in pharmaceutical formulations |
| 07/12/2006 | EP1441718B1 Use of carbinols for the treatment of neuropathic dysfunction |
| 07/12/2006 | CN1802348A Mercapto-phenyl-naphthyl-methane derivatives and preparation thereof |
| 07/12/2006 | CN1263757C Compounds specific to adenosine A1, A2, and A3 receptor and uses thereof |
| 07/12/2006 | CN1263755C Pyrazolopyridine derivatives as selective COX-2 inhibitors |
| 07/12/2006 | CN1263720C Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 07/12/2006 | CN1263453C Pharmaceutical composition based on micronized progesterone, preparation method and uses thereof |
| 07/11/2006 | US7074933 quinolin-2-ones and chromen-2-ones compounds that have been derivatized at the 6-position with a urea or thiourea derivative; used as androgen antagonists; kits |
| 07/11/2006 | US7074929 Certain alkylene diamine-substituted heterocycles |
| 07/11/2006 | US7074829 Antiestrogens, process for their production and their pharmaceutical use |
| 07/11/2006 | US7074819 Benzopyran or thiobenzopyran derivatives |
| 07/11/2006 | US7074815 4-[3,5-bis-(2-hydroxy-phenyl)-[1,2,4]triazol-1-yl]-benzoic acid derivatives for treating an excess of metal in the body |
| 07/11/2006 | US7074806 Antiinflammatory agents, antiallergens, antiproliferative agents, immunosuppressants, antidiabetic agents, cardiovascular disorders |
| 07/11/2006 | US7074795 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 07/11/2006 | US7074781 E.g., 1-(2-methyl-4-(2,3,4,5-tetrahydro-1-benzazepin-1-ylcarbonyl)benzylcarbamoyl)-L-proline-N,N-dimethylamide; control of urinary incontinence and bleeding disorders. |
| 07/11/2006 | US7074403 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 07/11/2006 | CA2395114C 3-thiazol-4-yl-pyprolidine derivatives as amp-specific phosphodiesterase inhibitors |
| 07/11/2006 | CA2158609C 5 .alpha.-reductase inhibitors |
| 07/11/2006 | CA2090584C Steroids having a methylene lactone group at position 17, process for preparing the same and their intermediates, use of the same as drugs and pharmaceutical compositions comprising the same |
| 07/06/2006 | WO2006069787A1 Decaline-derived compounds as pharmaceutically active agents |
| 07/06/2006 | WO2006069466A1 Series of triterpenoid ptp1b inhibitors and their preparing method and use |
| 07/06/2006 | US20060149033 IGF antagonist peptides |
| 07/06/2006 | US20060148893 Chemical compounds |
| 07/06/2006 | US20060148816 17Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 07/06/2006 | US20060148798 Antiinflammatory agents; cardiovascular disorders; antidiabetic agents;central nervous system diosrders ; anticancer agents |
| 07/06/2006 | US20060148793 beta-aryl-alpha-oxysubstituted alkylcarboxylic acids, usch as Ethyl (E/Z)-3-[4-[2-(phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxypropenoate, used as antilipemic or hypoglycemic agents |
| 07/06/2006 | US20060148792 Substituted 1,4-benzodiazepines and uses thereof |
| 07/06/2006 | US20060148775 E.g., budesonide dodecylcarbonate and budesonide 2-dimethylaminoethyl carbonatewith agonists such as albuterol, formoterol, or salmeterol; used for inducing bronchodilation and treating COPD, asthma and rhinitis. |
| 07/06/2006 | US20060148768 Vitamin d3 lactone derivatives |
| 07/06/2006 | US20060148754 Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus and insulin resistance |
| 07/06/2006 | US20060148018 Insulin-like growth factor binding protein-4 protease |
| 07/06/2006 | US20060147437 Use of pigmented retinal epithelial cells for creation of an immune privilege site |
| 07/05/2006 | EP1676862A1 Recombinant antibody against human insulin-like growth factor |
| 07/05/2006 | EP1675867A1 Estrogen extraction from pregnant animal urine |
| 07/05/2006 | EP1399441B1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 07/05/2006 | EP1250328B1 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 07/05/2006 | EP1248626B1 Pharmaceutical compositions containing steroidal structures and uses thereof |
| 07/05/2006 | EP1225894B1 Fab i inhibitors |
| 07/05/2006 | EP1133522B1 Antagonistic analogs of gh-rh inhibiting igf-i and -ii |
| 07/05/2006 | EP0733109B9 Bmp-12, bmp-13 and tendon-inducing compositions thereof |
| 07/05/2006 | CN1798721A Cyclohexyl derivatives as selective estrogen receptor modulators |
| 07/05/2006 | CN1796558A Isolated nucleic acid molecules which encode T cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof |
| 07/05/2006 | CN1262560C 4-halogenated 17-methylene steroids, method for production thereof and pharmaceutical compositions contg. these compounds |
| 07/05/2006 | CN1262541C Tricyclic protein kinase inhibitors |
| 07/05/2006 | CN1262540C Bicycle androgen and progesterone receptor modulator compounds and methods |
| 07/04/2006 | US7071300 IGF antagonist peptides |
| 07/04/2006 | US7071200 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 07/04/2006 | US7071179 Method of locking 1α-OH of vitamin D compounds in axial orientation |
| 07/04/2006 | US7071165 LHRH antagonist peptides |
| 07/04/2006 | US7071160 Integrin binding polipeptide for diagnosis, prevention and treatment of renal failure, thrombosis, osteoporosis, cancers and diabetes |
| 07/04/2006 | US7070971 enzyme inhibitor for selectin mediated binding events and methods of treating disease conditions using animal models; genetic engineering |
| 07/04/2006 | US7070784 Method for down-regulating GDF-8 activity using immunogenic GDF-8 analogues |
| 07/04/2006 | US7070759 High dose radionuclide complexes for bone marrow suppression |
| 07/04/2006 | CA2404848C Indole carboxylic acids as thyroid receptor ligands |
| 07/04/2006 | CA2332066C Tetrazole compounds as thyroid receptor ligands |
| 06/29/2006 | WO2006069202A2 Compositions comprising anti-igf-i receptor antibodies and methods for obtaining said antibodies |
| 06/29/2006 | WO2006068326A1 Novel polypeptide and the use thereof |
| 06/29/2006 | WO2006066868A2 Sustained release formulation comprising bisphosphonate |
| 06/29/2006 | WO2005107730A3 Cysteamines for treating complications of hypercholesterolemia and diabetes |
| 06/29/2006 | US20060142354 Use of epothilone derivatives for the treatment of hyperparathyroidism |
| 06/29/2006 | US20060142338 Androgen sensitive diseases; prostate cancer; skin disorders; alopecia |
| 06/29/2006 | US20060142334 Tetrahydroquinoline derivatives |
| 06/29/2006 | US20060142309 8-Heteroaryl xanthine adenosine A2B receptor antagonists |
| 06/29/2006 | US20060142267 [6-hydroxy-2-(2-hydroxy-benzyl)-benzo [b]thiophen-3-yl]-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-methanone; [6-hydroxy-2-(2-hydroxy-benzyl)-naphthalen-1-yl]-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-methanone; 6-(2-hydroxy-benzyl)-5-{hydroxy-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-methyl}-naphthalen-2-ol |
| 06/29/2006 | US20060142264 Novel amide derivatives |
| 06/29/2006 | US20060142258 Estrogen replacement therapy |
| 06/29/2006 | US20060140937 B7-related nucleic acids and polypeptides useful for immunomodulation |
| 06/29/2006 | US20060140913 Regeneration initiating cells |
| 06/29/2006 | US20060140907 Central airway administration for systemic delivery of therapeutics |
| 06/29/2006 | DE102004062182A1 Transdermales Pflaster mit Progesteron A-Spezifische Liganden (PRASL) als Wirkstoff Transdermal patch with progesterone A-specific ligands (PRASL) as active ingredient |
| 06/29/2006 | CA2592201A1 Neuromedin s and the use thereof |
| 06/29/2006 | CA2591304A1 Compositions and methods relating to anti-igf-1 receptor antibodies |
| 06/29/2006 | CA2585116A1 Sustained release formulation comprising bisphosphonate |
| 06/28/2006 | EP1674454A1 SUBSTITUTED 2-AMINO- 1,2,4 TRIAZOLO 1,5-a PYRIMIDINE DERIVATIVE AND USE THEREOF |
| 06/28/2006 | EP1674090A1 Early insulin secretion promoter |
| 06/28/2006 | EP1674089A1 Accelerator for initial insulin secretion |
| 06/28/2006 | EP1673376A2 Treating bone-related disorders with selective androgen receptor modulators |
| 06/28/2006 | EP1673355A1 Substituted triazole derivatives as oxytocin antagonists |
| 06/28/2006 | EP1673093A1 Use of steroidal quinols for estrogen replacement therapy |
| 06/28/2006 | EP1673088A1 1,1,1- trifluoro-4-phenyl-4-methyl-2-(1h-pyrrolo¬2,3-c|pyridin-2-ylmethyl)pentan-2-ol derivatives and related compounds as glucocorticoid ligands for the treatment of inflammatory diseases and diabetes |
| 06/28/2006 | EP1673063A1 Transdermal pharmaceutical composition |
| 06/28/2006 | EP1255536B1 Indolinone derivatives for modulation of c-kit tyrosine protein kinase |
| 06/28/2006 | EP0783585B1 DEFFECTIVE RECOMBINANT ADENOVIRUSES WITH INACTIVATED IVa2 GENE |
| 06/28/2006 | CN1795206A Galectin 9-inducing factors |
| 06/28/2006 | CN1795193A N-acyl nitrogen heterocyles as ligands of peroxisome proliferator-activated receptors |
| 06/28/2006 | CN1261431C 2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof |
| 06/28/2006 | CN1261158C Application of growth hormone for preparation medicine with induced nerve protection function |
| 06/28/2006 | CN1261145C Medicine for treating goiter |
| 06/28/2006 | CN1261099C Tetrahydroquinoline derivatives |
| 06/27/2006 | US7067539 Cannabinoid receptor ligands |
| 06/27/2006 | US7067525 Compounds useful as modulators of Melanocortin Receptors and pharmaceutical compositions comprising same |
| 06/27/2006 | US7067524 estrogen receptor agaonists or antagonists; therapy or prophylaxis for endometriosis; 8-fluoro-6-(3-fluoro-4-hydroxyphenyl)-2-naphthol |